Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Camp4 Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CAMP.
You can purchase shares of Camp4 Therapeutics (NASDAQ:CAMP) through any online brokerage.
Other companies in Camp4 Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), OncoCyte (NASDAQ:OCX) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Camp4 Therapeutics has a consensus price target of $9.40.
The stock price for Camp4 Therapeutics (NASDAQ: CAMP) is $5.5 last updated March 12, 2025 at 8:11 AM EDT.
There are no upcoming dividends for Camp4 Therapeutics.
Camp4 Therapeutics’s Q3 earnings are confirmed for Thursday, November 21, 2024.
There is no upcoming split for Camp4 Therapeutics.
Camp4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.